TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+41.54%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$837M
AUM Growth
+$837M
(+43%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
13.57%
Top 10 Holdings %
Top 10 Hldgs %
97.79%
Holding
19
New
7
Increased
2
Reduced
3
Closed
2
Top Buys
| 1 |
Relmada Therapeutics
RLMD
|
$50.7M |
| 2 |
Evolus
EOLS
|
$32.1M |
| 3 |
AnaptysBio
ANAB
|
$30M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$16.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$7.18M |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$11.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$11.1M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3M |
| 4 |
NCNA
NuCana
NCNA
|
$1.53M |
| 5 |
Cellectar Biosciences
CLRB
|
$471K |
Sector Composition
| 1 | Healthcare | 99.96% |
